Smith Group Asset Management LLC Purchases 16,200 Shares of Doximity, Inc. (NASDAQ:DOCS)

Smith Group Asset Management LLC boosted its position in shares of Doximity, Inc. (NASDAQ:DOCS) by 163.0% in the fourth quarter, Holdings Channel reports. The firm owned 26,140 shares of the company’s stock after purchasing an additional 16,200 shares during the period. Smith Group Asset Management LLC’s holdings in Doximity were worth $1,396,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of the company. UMB Bank n.a. boosted its position in shares of Doximity by 69.1% during the fourth quarter. UMB Bank n.a. now owns 575 shares of the company’s stock worth $31,000 after purchasing an additional 235 shares in the last quarter. Farther Finance Advisors LLC raised its stake in Doximity by 324.2% during the 3rd quarter. Farther Finance Advisors LLC now owns 789 shares of the company’s stock worth $34,000 after buying an additional 603 shares during the period. Quarry LP lifted its holdings in Doximity by 101.2% during the second quarter. Quarry LP now owns 1,616 shares of the company’s stock worth $45,000 after acquiring an additional 131,253 shares in the last quarter. Morse Asset Management Inc acquired a new position in Doximity in the third quarter valued at about $46,000. Finally, GAMMA Investing LLC increased its holdings in shares of Doximity by 40.1% in the third quarter. GAMMA Investing LLC now owns 1,439 shares of the company’s stock worth $63,000 after acquiring an additional 412 shares in the last quarter. Institutional investors own 87.19% of the company’s stock.

Doximity Stock Performance

DOCS opened at $57.17 on Wednesday. The business’s 50-day simple moving average is $53.98 and its 200 day simple moving average is $44.06. Doximity, Inc. has a 52-week low of $22.96 and a 52-week high of $61.75. The firm has a market capitalization of $10.67 billion, a PE ratio of 61.57, a PEG ratio of 4.43 and a beta of 1.38.

Doximity (NASDAQ:DOCS) last announced its quarterly earnings data on Thursday, November 7th. The company reported $0.24 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.26 by ($0.02). Doximity had a return on equity of 19.79% and a net margin of 33.69%. The company had revenue of $136.83 million for the quarter, compared to the consensus estimate of $127.05 million. During the same quarter in the prior year, the company earned $0.18 EPS. On average, research analysts forecast that Doximity, Inc. will post 0.88 earnings per share for the current year.

Analyst Ratings Changes

Several equities analysts have recently weighed in on DOCS shares. Evercore ISI lifted their price objective on Doximity from $34.00 to $45.00 and gave the company an “in-line” rating in a report on Tuesday, October 8th. Truist Financial lifted their price target on shares of Doximity from $35.00 to $49.00 and gave the company a “hold” rating in a research note on Thursday, November 14th. Raymond James reissued an “outperform” rating and set a $65.00 price objective (up previously from $37.00) on shares of Doximity in a research report on Friday, November 8th. The Goldman Sachs Group initiated coverage on shares of Doximity in a report on Friday, November 15th. They set a “neutral” rating and a $58.00 price objective on the stock. Finally, Barclays upped their target price on shares of Doximity from $52.00 to $75.00 and gave the stock an “overweight” rating in a research note on Monday, November 11th. Thirteen research analysts have rated the stock with a hold rating, six have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat, Doximity currently has a consensus rating of “Hold” and a consensus target price of $53.12.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.